Norway - Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Government Schemes and Compulsory Contributory Health Care Financing Schemes
Since 2014, Norway Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Government Schemes and Compulsory Contributory Health Care Financing Schemes decreased by 0.5% year on year. With €282.56 Per Capita in 2019, the country was number 10 among other countries in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Government Schemes and Compulsory Contributory Health Care Financing Schemes. Norway is overtaken by Italy, which was number 9 with €284.66 Per Capita and is followed by Sweden with €272.33 Per Capita. Switzerland lead the ranking with €666.37 Per Capita in 2019, +3.2% compared to 2018. Germany, Liechtenstein and Ireland respectively ranked number 2, 3 and 4 in this ranking. Latvia recorded the best 5 years average growth at +8.8% per year, while Romania witnessed the worst performance at -1.7% per year.
Loading...
Date | Euros Per Capita |
---|---|
2019 | 282.56 |
2018 | 280.69 |
2017 | 291.03 |
2016 | 285.59 |
2015 | 299.64 |
How does Norway rank in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Government Schemes and Compulsory Contributory Health Care Financing Schemes?
# | 33 Countries | Euros Per Capita | Last | YoY | 5‑years CAGR | ||
---|---|---|---|---|---|---|---|
1 |
#1
Switzerland
|
666.37 | 2019 | +3.1 % | +5.3 % | View data | |
2 |
#2
Germany
|
553.39 | 2019 | +2.3 % | +3.0 % | View data | |
9 |
#9
Italy
|
284.66 | 2019 | +0.3 % | +2.7 % | View data | |
10 |
#10
Norway
|
282.56 | 2019 | +0.7 % | -0.5 % | View data | |
11 |
#11
Sweden
|
272.33 | 2019 | +1.1 % | +1.7 % | View data |